Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034383 · ClinicalTrials.gov registry record · NA
The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet
A NA study, sponsored by David Baer.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02034383: Completed NA study, sponsored by David Baer.
NCT02034383 is a NA study that has completed, run by David Baer. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034383, a NA study, has completed, sponsored by David Baer.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objective of this study is to measure the effect of processing (roasting, slicing, or grinding) on the energy value of almonds in the human diet and study molecular mechanisms that may help explain the beneficial health effects of almonds.
Primary Outcome
The metabolizable energy value of almonds and almond butter will be calculated based on the chemical composition and energy content of the consumed diet and excreta.
Interventions
- OTHER Control
- OTHER Almond Butter
- OTHER Whole Almonds
- OTHER Roasted Whole Almonds
- OTHER Diced Almonds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT02034383 record still lists
NCT02034383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Control is the first listed.
NCT02034383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02034383 about?
NCT02034383 is a clinical study titled "The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet". The objective of this study is to measure the effect of processing (roasting, slicing, or grinding) on the energy value of almonds in the human diet and study molecular mechanisms that may help explain the beneficial health effects of almonds.
What is the current status of trial NCT02034383?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-03. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02034383?
The interventions under investigation include: Control (OTHER), Almond Butter (OTHER), Whole Almonds (OTHER), Roasted Whole Almonds (OTHER), Diced Almonds (OTHER).
Who is sponsoring clinical trial NCT02034383?
This trial is sponsored by David Baer, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02034383's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia